These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 19280301

  • 1. Mycobacterium abscessus from respiratory isolates: activities of drug combinations.
    Cremades R, Santos A, Rodríguez JC, Garcia-Pachón E, Ruiz M, Royo G.
    J Infect Chemother; 2009 Feb; 15(1):46-8. PubMed ID: 19280301
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
    Singh S, Bouzinbi N, Chaturvedi V, Godreuil S, Kremer L.
    Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
    [Abstract] [Full Text] [Related]

  • 3. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
    Zhang Z, Lu J, Liu M, Wang Y, Zhao Y, Pang Y.
    Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic resistance in Mycobacterium Abscessus and Mycobacterium Fortuitum isolates from Malaysian patients.
    Jayasingam SD, Zin T, Ngeow YF.
    Int J Mycobacteriol; 2017 Mar; 6(4):387-390. PubMed ID: 29171453
    [Abstract] [Full Text] [Related]

  • 6. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 7. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, Shen GH.
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [Abstract] [Full Text] [Related]

  • 8. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS, Chang SC, Shen EP, Hu FR.
    PLoS One; 2015 Mar; 10(1):e0116236. PubMed ID: 25581038
    [Abstract] [Full Text] [Related]

  • 9. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M, Fisher S, Story-Roller E, Lamichhane G, Parrish N.
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [Abstract] [Full Text] [Related]

  • 10. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
    Cremades R, Santos A, Rodríguez JC, Garcia-Pachon E, Ruiz M, Royo G.
    J Chemother; 2008 Feb; 20(1):43-7. PubMed ID: 18343742
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G, Pang H, Guo Q, Huang M, Tan Y, Li C, Wei J, Xia Y, Jiang Y, Zhao X, Liu H, Zhao LL, Liu Z, Xu D, Wan K.
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [Abstract] [Full Text] [Related]

  • 12. In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex.
    Cheng A, Tsai YT, Chang SY, Sun HY, Wu UI, Sheng WH, Chen YC, Chang SC.
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [Abstract] [Full Text] [Related]

  • 13. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M, Burian J, Thompson CJ.
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
    Kamada K, Yoshida A, Iguchi S, Arai Y, Uzawa Y, Konno S, Shimojima M, Kikuchi K.
    Sci Rep; 2021 Jun 09; 11(1):12208. PubMed ID: 34108590
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
    Somoskovi A, Salfinger M.
    Clin Lab Med; 2014 Jun 09; 34(2):271-95. PubMed ID: 24856528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.